The role of norepinephrine in the pathophysiology of cognitive disorders: potential applications to the treatment of cognitive dysfunction in schizophrenia and Alzheimer's disease.
about
Piperidine-based nocaine/modafinil hybrid ligands as highly potent monoamine transporter inhibitors: efficient drug discovery by rational lead hybridization.Adrenergic pharmacology and cognition: focus on the prefrontal cortexCannabinoid modulation of noradrenergic circuits: implications for psychiatric disordersApomorphine and the dopamine hypothesis of schizophrenia: a dilemma?Schizophrenia: redox regulation and volume neurotransmissionAntipsychotic drugs: comparison in animal models of efficacy, neurotransmitter regulation, and neuroprotectionClonidine normalizes sensorimotor gating deficits in patients with schizophrenia on stable medication.Effects of caffeine or RX821002 in rats with a neonatal ventral hippocampal lesionTheranostic Biomarkers for SchizophreniaPharmacological treatment of schizophrenia: a critical review of the pharmacology and clinical effects of current and future therapeutic agents.Treatments for schizophrenia: a critical review of pharmacology and mechanisms of action of antipsychotic drugs.Metabolomic changes in autopsy-confirmed Alzheimer's diseaseIdentification of altered metabolic pathways in plasma and CSF in mild cognitive impairment and Alzheimer's disease using metabolomics.On the origin of cortical dopamine: is it a co-transmitter in noradrenergic neurons?Biogenic amines and polyamines: similar biochemistry for different physiological missions and biomedical applications.Boron-doped diamond nano/microelectrodes for biosensing and in vitro measurementsAmyloid beta peptide-(1-42) induces internalization and degradation of beta2 adrenergic receptors in prefrontal cortical neuronsThe involvement of noradrenaline in rapid eye movement sleep mentation.The Effects of Methylphenidate on Resting-State Functional Connectivity of the Basal Nucleus of Meynert, Locus Coeruleus, and Ventral Tegmental Area in Healthy Adults.Enviromimetics: exploring gene environment interactions to identify therapeutic targets for brain disorders.The neuropsychology of cannabis and other substance use in schizophrenia: review of the literature and critical evaluation of methodological issues.Internalizing versus externalizing comorbidity: neural circuit hypothesis.Can genetics inform the management of cognitive deficits in schizophrenia?A Neurophysiological and Neuropsychological Consideration of Mindful Movement: Clinical and Research Implications.Noradrenaline activation of neurotrophic pathways protects against neuronal amyloid toxicity.Clonidine normalizes levels of P50 gating in patients with schizophrenia on stable medication.Relations of clinical features, subgroups and medication to serum monoamines in schizophrenia.Novel form of long-term synaptic depression in rat hippocampus induced by activation of alpha 1 adrenergic receptors.Association study of an SNP combination pattern in the dopaminergic pathway in paranoid schizophrenia: a novel strategy for complex disorders.Fine-grained versus categorical: Pupil size differentiates between strategies for spatial working memory performance.Investigation of the role of alpha-2 adrenergic receptors on prepulse inhibition of acoustic startle reflex in rats.Kinetics of serotonin oxidation by heme-Aβ relevant to Alzheimer's disease.A combination of nordihydroguaiaretic acid as an electron transfer mediator and multi-walled carbon nanotubes for simultaneous electrocatalytic determination of noradrenaline, uric acid, and tryptophanNutritional modulation of the intestinal microbiota; future opportunities for the prevention and treatment of neuroimmune and neuroinflammatory disease
P2860
Q24544227-35AE2DE4-12AB-4AD5-B994-3D7ECBB261A9Q24684217-0F0F9299-DE23-46C5-93D8-E727C5EB7E2EQ27001139-FF76C7F1-5670-423A-A901-08D81C08AA73Q28366409-FAE2907B-BB5D-4B71-B671-CA0F996570D1Q28742799-9BB1C9C7-466C-495B-B2AA-7134996006E1Q30386608-EDAB612C-6A9D-488A-9310-706E56339FE7Q30439307-A0D9ACFE-31ED-465E-8F8E-CC65446466AFQ30443847-B941E395-10A3-4A3C-8B71-876787E40CF4Q33624412-1BB56C7D-524A-4205-B1AC-B79188C4458EQ34274859-C3093BB7-9217-472C-B92F-627ECEA9BC91Q34338202-4E9E92EA-2C46-4F80-B99B-2816BDA8A816Q34700264-1EA8FBA2-CCC7-4A98-8894-D6E84BFC0B88Q34735142-9EA55949-CA86-4948-8661-E1296918A9ACQ34794235-AACE9CE2-B6EB-476C-A964-AF10CC1EB8F5Q35086731-AD614036-23FE-4971-9A59-55C2A31801A7Q35091761-397EFE88-4FAF-44D5-BBC2-B53E2D0A45D1Q35213182-F89D7FDF-3744-4AB1-80FF-12F78E159EC6Q35607222-3EA14AC2-8286-422C-A4C0-BC18983F5557Q36805793-7F049DFD-55DB-4EBF-B30C-6373261CE925Q36871981-91459A03-97C7-4452-A339-062F175BEB31Q36965847-F362FA65-299F-461B-BF72-F58506DF651AQ37732221-DDD29D56-F4B5-4522-86B1-0BE19E5E3322Q37983548-D44753E1-C118-42F0-B30D-ECF303BB82ACQ38527778-76C3EC3F-F977-4ED6-A842-68623AD76122Q39743698-40B72180-F1A0-4983-BE85-2F41A940A538Q42219614-B5B80993-4A69-4C8B-9749-24E6AED51AB3Q44197234-93799C52-8169-4CCC-B90E-F46857EAE846Q44628469-319C22B9-1245-4B64-8701-FA437114B946Q44743802-2BF3CE58-4F8D-43B6-94C3-D706C022A51CQ47239934-74683BD9-0D16-482C-B08F-703FEBACF714Q48475935-EECFC3B2-F5B1-4D69-8859-C92B82F529ACQ53469156-80F44F35-A770-4C16-BDE2-AFEC17BDDF09Q57376645-100901EC-644D-40B4-83D8-58F76CA2B7DBQ61847159-cc54c0ba-4f00-f4ef-b93d-e326b42f2a42
P2860
The role of norepinephrine in the pathophysiology of cognitive disorders: potential applications to the treatment of cognitive dysfunction in schizophrenia and Alzheimer's disease.
description
1999 nî lūn-bûn
@nan
1999 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
The role of norepinephrine in ...... renia and Alzheimer's disease.
@ast
The role of norepinephrine in ...... renia and Alzheimer's disease.
@en
type
label
The role of norepinephrine in ...... renia and Alzheimer's disease.
@ast
The role of norepinephrine in ...... renia and Alzheimer's disease.
@en
prefLabel
The role of norepinephrine in ...... renia and Alzheimer's disease.
@ast
The role of norepinephrine in ...... renia and Alzheimer's disease.
@en
P2093
P921
P1476
The role of norepinephrine in ...... renia and Alzheimer's disease.
@en
P2093
P304
P356
10.1016/S0006-3223(99)00232-2
P407
P577
1999-11-01T00:00:00Z